Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of κ-opioid receptors

Journal of Neuroscience

Volumn 23, Issue 19, 2003, Pages 7262-7268

  Bie, Bihua ^a   Pan, Zhizhong Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Analgesia; Glutamate; Hyperalgesia; Opioid; Pain; receptors; receptors

Indexed keywords

ANALGESIC AGENT; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR; AMINO ACID RECEPTOR BLOCKING AGENT; BENZENEACETAMIDE DERIVATIVE; DYNORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GLUTAMIC ACID; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NARCOTIC ANALGESIC AGENT; PRESYNAPTIC RECEPTOR; PYRROLIDINE DERIVATIVE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG DEPENDENCE; DRUG WITHDRAWAL; FACILITATION; HYPERALGESIA; MALE; NERVE CELL PLASTICITY; NERVOUS SYSTEM FUNCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PAIN; PATCH CLAMP; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SYNAPTIC TRANSMISSION; ANIMAL; ANIMAL BEHAVIOR; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EXCITATORY POSTSYNAPTIC POTENTIAL; PHYSIOLOGY; RAPHE NUCLEUS; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BENZENEACETAMIDES; CELLS, CULTURED; DYNORPHINS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; HYPERALGESIA; MALE; PATCH-CLAMP TECHNIQUES; PYRROLIDINES; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECEPTORS, PRESYNAPTIC; SYNAPTIC TRANSMISSION;

EID: 0043240308     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-19-07262.2003     Document Type: Article

References (38)

1. Ackley MA, Hurley RW, Virnich DE, Hammond DL (2001) A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain 91:377-388.
2. Aimone LD, Gebhart GF (1986) Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla. J Neurosci 6:1803-1813.
3. Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J, Sarosi I, Woodgett JR, Oliveira-dos-Santos AJ, Ikura M, van der Kooy D, Salter MW, Penninger JM (2002) DREAM is a critical transcriptional repressor for pain modulation. Cell 108:31-43.
4. Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259-285.
5. Fields H, Basbaum A (1999) Central nervous system mechanisms of pain modulation. In: Textbook of pain, 4E Ed (Wall P, Melzack R, eds). London: Churchill Livingstone.
6. Fundytus ME (2001) Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15:29-58.
7. Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabinoids are mediated by μ-opioid and κ-opioid receptors. J Neurosci 22:1146-1154.
8. Heinricher MM, Schouten JC, Jobst EE (2001) Activation of brainstem N-methyl-D-aspartate receptors is required for the analgesic actions of morphine given systemically. Pain 92:129-138.
9. Hjelmstad GO, Fields HL (2001) Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell. J Neurophysiol 85:1153-1158.
10. Jacquet YF (1988) The NMDA receptor: central role in pain inhibition in rat periaqueductal gray. Eur J Pharmacol 154:271-276.
11. Kalyuzhny AE, Wessendorf MW (1999) Serotonergic and GABAergic neurons in the medial rostral ventral medulla express kappa-opioid receptor immunoreactivity. Neuroscience 90:229-234.
12. Kaplan H, Fields H (1991) Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J Neurosci 11:1433-1439.
13. Kim DH, Fields HL, Barbaro NM (1990) Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes. Brain Res 516:37-40.
14. Lipa SM, Kavaliers M (1990) Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res Bull 24:627-630.
15. Manabe T, Wyllie DJ, Perkel DJ, Nicoll RA (1993) Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. J Neurophysiol 70:1451-1459.
16. Manzoni OJ, Williams JT (1999) Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J Neurosci 19:6629-6636.
17. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823.
18. Nestler EJ (1996) Under siege: The brain on opiates. Neuron 16:897-900.
19. Pan ZZ (1998) mu-opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19:94-98.
20. Pan ZZ, Williams JT, Osborne P (1990) Opioid actions on single raphe magnus neurons from rat and guinea pig in vitro. J Physiol (Lond) 427:519-532.
21. Pan ZZ, Tershner SA, Fields HL (1997) Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor. Nature 389:382-385.
22. Pan ZZ, Hirakawa N, Fields HL (2000) A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26:515-522.
23. Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan Jr TP, Ossipov MH, Lappi DA, Lai J (2001) Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the μ-opioid receptor. J Neurosci 21:5281-5288.
24. Porreca F, Ossipov MH, Gebhart GF (2002) Chronic pain and medullary descending facilitation. Trends Neurosci 25:319-325.
25. Randic M, Cheng G, Kojic L (1995) κ-opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord. J Neurosci 15:6809-6826.
26. Schmidt BL, Tambeli CH, Levine JD, Gear RW (2002) mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur J Neurosci 15:861-868.
27. Spinella M, Cooper ML, Bodnar RJ (1996) Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain 64:545-552.
28. Takahashi M, Senda T, Kaneto H (1991) Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine. Eur J Pharmacol 200:293-297.
29. Takemori AE, Loh HH, Lee NM (1992) Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur J Pharmacol 221:223-226.
30. Tao PL, Hwang CL, Chen CY (1994) U-50, 488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs. Eur J Pharmacol 256:281-286.
31. Tershner SA, Mitchell JM, Fields HL (2000) Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function. Pain 85:153-159.
32. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
33. Trujillo KA, Akil H (1995) Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 38:139-154.
34. Urban MO, Gebhart GF (1998) The glutamate synapse: a target in the pharmacological management of hyperalgesic pain states. Prog Brain Res 116:407-420.
35. Urban MO, Gebhart GF (1999) Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 96:7687-7692.
36. Wagner JJ, Terman GW, Chavkin C (1993) Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363:451-454.
37. Weisskopf MG, Zalutsky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362:423-427.
38. Zhuo M, Gebhart GF (1997) Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. J Neurophysiol 78:746-758.